1. Pink Sheet

Pharma ‘Doing The Right Thing By Patients,’ Major Trial Transparency Study Finds

 
• By Neena Brizmohun

Authors of new a study find that while most pharma companies are complying with rules for reporting trial results on the EU Clinical Trials Register, too many trials are still not being reported. They hope their newly launched online EUTrialsTracker tool might help address the situation.

PS1809_Clinical Trial_303308024_1200.jpg
A new online tool will help track compliance with trial report rules • Source: Shutterstock

Drug companies are outstripping academics when it comes to complying with the EU rules on reporting clinical trial results, but while pharma is doing well on this front, results from too many trials are still going unreported, according to a new study.

Only around half of the 7,274 trials that should have complied with the requirement to post results on the EU Clinical Trials Register (EUCTR) have done so, reveals the study, which was led by the AllTrials transparency

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D